• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处方监测计划的使用如何改变药学实践?

How does use of a prescription monitoring program change pharmacy practice?

机构信息

Rhode Island Hospital, 55 Claverick St., 2nd floor, Providence, RI 02903, USA.

出版信息

J Am Pharm Assoc (2003). 2013 May-Jun;53(3):273-81. doi: 10.1331/JAPhA.2013.12094.

DOI:10.1331/JAPhA.2013.12094
PMID:23699676
Abstract

OBJECTIVES

To assess differences in prescription monitoring program (PMP) use between two states with different PMP accessibility (Connecticut [CT] and Rhode Island [RI]), to explore use of PMPs in pharmacy practice, and to examine associations between PMP use and pharmacists' responses to suspected diversion or "doctor shopping."

DESIGN

Descriptive nonexperimental study.

SETTING

CT and RI from March through August 2011.

PARTICIPANTS

Licensed pharmacists in CT and RI.

INTERVENTION

Anonymous surveys e-mailed to pharmacists

MAIN OUTCOME MEASURES

PMP use, use of patient reports in pharmacy practice, and responses to suspected doctor shopping or diversion.

RESULTS

Responses from 294 pharmacists were received (CT: 198; RI: 96). PMP users were more likely to use the PMP to detect drug abuse (CT: 79%; RI: 21.9%; P < 0.01) and doctor shopping (67%; 7%; P < 0.01). When faced with suspicious medication use behavior, PMP users were less likely than nonusers to discuss their concerns with the patient (adjusted odds ratio 0.48 [95% CI 0.25-0.92]) but as likely to contact the provider (0.86 [0.21-3.47]), refer the patient back to the prescriber (1.50 [0.79-2.86]), and refuse to fill the prescription (0.63 [0.30-1.30]). PMP users were less likely to state they were out of stock of the drug (0.27 [0.12-0.60]) compared with nonusers. Pharmacists reported high interest in attending continuing education on safe dispensing (72.8%).

CONCLUSION

Pharmacists are important participants in the effort to address prescription drug misuse and abuse. Current PMP use with prevailing systems had limited influence on pharmacy practice. Findings point to future research and needed practice and education innovations to improve patient safety and safer opioid dispensing for pharmacists.

摘要

目的

评估两个州(康涅狄格州[CT]和罗得岛州[RI])在处方监测计划(PMP)使用方面的差异,探讨 PMP 在药房实践中的使用情况,并检验 PMP 使用与药师对疑似药物滥用或“医生购物”的反应之间的关联。

设计

描述性非实验性研究。

地点

2011 年 3 月至 8 月的 CT 和 RI。

参与者

康涅狄格州和罗得岛州的持照药剂师。

干预措施

向药剂师发送匿名调查电子邮件。

主要观察指标

PMP 使用情况、在药房实践中使用患者报告情况,以及对疑似医生购物或药物滥用的反应。

结果

收到了 294 名药剂师的回复(CT:198;RI:96)。PMP 用户更有可能使用 PMP 来检测药物滥用(CT:79%;RI:21.9%;P<0.01)和医生购物(67%;7%;P<0.01)。当面临可疑的用药行为时,PMP 用户比非用户更不可能与患者讨论他们的担忧(调整后的优势比 0.48[95%CI 0.25-0.92]),但同样可能与提供者联系(0.86[0.21-3.47])、将患者转介给开处方者(1.50[0.79-2.86]),以及拒绝配药(0.63[0.30-1.30])。与非用户相比,PMP 用户表示药品缺货的可能性较小(0.27[0.12-0.60])。药剂师报告对参加安全配药继续教育有浓厚兴趣(72.8%)。

结论

药剂师是解决处方药物滥用问题的重要参与者。当前 PMP 的使用与现行系统结合,对药房实践的影响有限。研究结果表明,需要进行未来研究和必要的实践与教育创新,以提高患者安全和药剂师更安全地配药阿片类药物。

相似文献

1
How does use of a prescription monitoring program change pharmacy practice?处方监测计划的使用如何改变药学实践?
J Am Pharm Assoc (2003). 2013 May-Jun;53(3):273-81. doi: 10.1331/JAPhA.2013.12094.
2
How does use of a prescription monitoring program change medical practice?处方监测计划的使用如何改变医疗实践?
Pain Med. 2012 Oct;13(10):1314-23. doi: 10.1111/j.1526-4637.2012.01452.x. Epub 2012 Jul 30.
3
Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.为患者筛查并讨论阿片类药物滥用问题的药剂师:研究与实践的未来方向。
J Pharm Pract. 2015 Aug;28(4):404-12. doi: 10.1177/0897190014522064. Epub 2014 Feb 13.
4
Prescribers and pharmacists requests for prescription monitoring program (PMP) data: does PMP structure matter?开处方者和药剂师对处方监测计划(PMP)数据的请求:PMP的结构重要吗?
J Pain Palliat Care Pharmacother. 2013 Jun;27(2):136-42. doi: 10.3109/15360288.2013.788598. Epub 2013 May 20.
5
Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.药剂师与开具管制药品处方相关的培训、认知角色及行为。
J Am Pharm Assoc (2003). 2014 May-Jun;54(3):241-50. doi: 10.1331/JAPhA.2014.13168.
6
Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.在药学实践中整合处方药监测计划(PDMP):改善临床决策并支持药剂师的专业判断。
Res Social Adm Pharm. 2016 Mar-Apr;12(2):257-66. doi: 10.1016/j.sapharm.2015.05.008. Epub 2015 Jun 6.
7
Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach.基于药房的全州纳洛酮分发:一种新颖的“自上而下、自下而上”方法。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S99-S106.e5. doi: 10.1016/j.japh.2017.01.017.
8
Factors influencing community pharmacists' enrollment in a state prescription monitoring program.影响社区药剂师参与州处方监测计划的因素。
J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):588-94. doi: 10.1331/JAPhA.2010.09089.
9
Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.美国印第安卫生服务部的药剂师参与了阿片类药物安全倡议,并扩大了纳洛酮的可及性。
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S135-S140. doi: 10.1016/j.japh.2017.01.005.
10
Do prescription monitoring programs impact state trends in opioid abuse/misuse?处方监测计划是否影响州内阿片类药物滥用/误用趋势?
Pain Med. 2012 Mar;13(3):434-42. doi: 10.1111/j.1526-4637.2012.01327.x. Epub 2012 Feb 2.

引用本文的文献

1
A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids.关于改善阿片类药物合理使用、减少阿片类药物使用障碍及处方阿片类药物所致死亡的策略的系统评价。
Can J Pain. 2018 Jul 31;2(1):218-235. doi: 10.1080/24740527.2018.1479842. eCollection 2018.
2
Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.医疗保健提供者对处方监测计划的利用:系统评价和荟萃分析。
Pain Med. 2021 Jul 25;22(7):1570-1582. doi: 10.1093/pm/pnaa412.
3
Strengths and weaknesses of existing data sources to support research to address the opioids crisis.
现有数据来源在支持应对阿片类药物危机研究方面的优势与不足。
Prev Med Rep. 2019 Nov 6;17:101015. doi: 10.1016/j.pmedr.2019.101015. eCollection 2020 Mar.
4
The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.州级阿片类药物滥用预防政策与患者和医疗服务提供者相关结局的关联:范围综述。
Milbank Q. 2020 Mar;98(1):57-105. doi: 10.1111/1468-0009.12436. Epub 2019 Dec 4.
5
Systematic Literature Review of Prescription Drug Monitoring Programs.处方药监测项目的系统文献综述
AMIA Annu Symp Proc. 2018 Dec 5;2018:1478-1487. eCollection 2018.
6
Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.利用处方药物监测计划进行处方和配药决策:一项多地点定性研究的结果。
Res Social Adm Pharm. 2019 Jun;15(6):754-760. doi: 10.1016/j.sapharm.2018.09.007. Epub 2018 Sep 14.
7
Promising roles for pharmacists in addressing the U.S. opioid crisis.药剂师在解决美国阿片类药物危机方面的大有可为。
Res Social Adm Pharm. 2019 Aug;15(8):910-916. doi: 10.1016/j.sapharm.2017.12.009. Epub 2017 Dec 31.
8
The opioid overdose epidemic: opportunities for pharmacists.阿片类药物过量流行:药剂师面临的机遇。
Subst Abuse Rehabil. 2017 Jul 31;8:53-55. doi: 10.2147/SAR.S144268. eCollection 2017.
9
Situational communication self-confidence among community pharmacists: A descriptive analysis.情境沟通自信在社区药剂师中的体现:描述性分析。
Res Social Adm Pharm. 2017 Nov;13(6):1175-1180. doi: 10.1016/j.sapharm.2016.12.003. Epub 2016 Dec 18.
10
Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review.识别和评估癌症患者阿片类药物滥用风险:一项综合综述。
Subst Abuse Rehabil. 2016 Jun 2;7:71-9. doi: 10.2147/SAR.S85409. eCollection 2016.